1
Home
Companies

Forward Pharma

Forward Pharma
Leadership team

Kristian Reich (Scientific Advisor)

Ulrich Mrowietz (Scientific Advisor)

Torsten Goesch (Director)

Products/ Services
Biopharma, Biotechnology, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Copenhagen, Hovedstaden, Denmark
Established
2005
Company Registration
SEC CIK number: 0001604924
Traded as
NASDAQ:FWP
URL
forward-pharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Forward Pharma is a global biopharmaceutical company focused on developing and commercializing treatments for debilitating autoimmune and inflammatory diseases. The company’s lead product candidates are FP187 and FP196, which are in clinical development for the treatment of multiple sclerosis and refractory Crohn’s disease, respectively.
History

Forward Pharma was founded in 2000 with the mission of developing innovative therapies to improve the lives of patients suffering from autoimmune and inflammatory diseases. The company has been a pioneer in immunomodulation, leveraging its expertise to develop and commercialize two novel product candidates. In 2014, the company secured a worldwide licensing agreement with Genentech for the commercialization of its lead product candidate, FP187. This agreement provided the company with the resources to expand and accelerate its product pipeline and commercialization efforts.

Mission
Forward Pharma is committed to developing and commercializing innovative therapies to improve the lives of patients suffering from autoimmune and inflammatory diseases.
Vision
Forward Pharma’s vision is to become the world’s leading biopharmaceutical company for the treatment of autoimmune and inflammatory diseases.
Key Team

Grant Hellier Lawrence (Independent Director)

Fred D. Lublin (Scientific Advisor)

Giancarlo Comi (Scientific Advisor)

Jakob Mosegaard Larsen (Director)

Florian Schonharting (Co-Founder & Chairman of the Board)

Duncan Moore (Independent Non-Executive Director)

Jerry S. Wolinsky (Scientific Advisor)

Per Soelberg Sørensen (Scientific Advisor)

Recognition and Awards
Forward Pharma has received numerous awards, including the prestigious FierceBiotech Innovation Award in 2016, the German Industry and Commerce Innovation Award in 2016, and the IFA Industry Award in 2020.
References

https://in.investing.com/equities/forward-pharma-adr-rep-1

https://www.crunchbase.com/organization/forward-pharma

forward-pharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Forward Pharma
Leadership team

Kristian Reich (Scientific Advisor)

Ulrich Mrowietz (Scientific Advisor)

Torsten Goesch (Director)

Products/ Services
Biopharma, Biotechnology, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Copenhagen, Hovedstaden, Denmark
Established
2005
Company Registration
SEC CIK number: 0001604924
Traded as
NASDAQ:FWP
URL
forward-pharma.com